Suppr超能文献

结直肠癌患者的淋巴结评估:一项基于人群的研究。

Lymph node evaluation in colorectal cancer patients: a population-based study.

作者信息

Baxter Nancy N, Virnig Dan J, Rothenberger David A, Morris Arden M, Jessurun Jose, Virnig Beth A

机构信息

Division of Surgical Oncology, Department of Surgery, University of Minnesota, 420 Delaware St. SE, Minneapolis, MN 55455, USA.

出版信息

J Natl Cancer Inst. 2005 Feb 2;97(3):219-25. doi: 10.1093/jnci/dji020.

Abstract

BACKGROUND

Adequate lymph node evaluation is required for proper staging of colorectal cancer, and the number of lymph nodes examined is associated with survival. According to current guidelines, the recommended minimum number of lymph nodes examined to ensure adequate sampling is 12. We used data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program to determine the proportion of colorectal cancer patients in the United States who receive adequate lymph node evaluation.

METHODS

For 116,995 adults with colorectal adenocarcinoma, diagnosed from 1988 through 2001, who underwent radical surgery and did not receive neoadjuvant radiation, we evaluated the number of lymph nodes, the likelihood of receiving adequate lymph node evaluation (i.e., at least 12 lymph nodes examined), and the influence of tumor and patient factors on lymph node evaluation. All statistical tests were two-sided.

RESULTS

Among all patients, the median number of lymph nodes examined was nine. Only 37% of all patients received adequate lymph node evaluation. The proportion of patients receiving adequate lymph node evaluation increased from 32% in 1988 to 44% in 2001 (P(trend)<.001, Cochran-Armitage test). Advanced tumor stage was statistically significantly associated with adequate lymph node evaluation (odds ratio [OR] of receiving adequate lymph node evaluation=2.27, 95% confidence interval [CI] = 2.18 to 2.35). Older patients (> or =71 years, OR = 0.45, 95% CI = 0.44 to 0.47) were less likely to receive adequate lymph node evaluation than younger patients, and those with left-sided (OR = 0.45, 95% CI = 0.44 to 0.47) or rectal (OR = 0.52, 95% CI = 0.50 to 0.54) cancers were less likely to receive adequate lymph node evaluation than patients with right-sided cancers. In all analyses, geographic location was an important predictor of adequate lymph node evaluation, which ranged from 33% to 53%, depending on geographic location.

CONCLUSIONS

In 2001, the majority of patients with colorectal cancer still received inadequate lymph node evaluation. The association of demographic variables, particularly patient age and geographic location, with adequate lymph node evaluation indicates that local surgical and pathology practice patterns may affect adequacy of lymph node evaluation.

摘要

背景

对结直肠癌进行准确分期需要充分评估淋巴结情况,所检查淋巴结的数量与生存率相关。根据现行指南,为确保充分采样,建议检查的淋巴结最小数量为12个。我们利用美国国立癌症研究所监测、流行病学和最终结果项目的数据,来确定美国接受充分淋巴结评估的结直肠癌患者比例。

方法

对于1988年至2001年期间诊断为结直肠腺癌、接受根治性手术且未接受新辅助放疗的116995名成年人,我们评估了淋巴结数量、接受充分淋巴结评估(即至少检查12个淋巴结)的可能性,以及肿瘤和患者因素对淋巴结评估的影响。所有统计检验均为双侧检验。

结果

在所有患者中,检查的淋巴结数量中位数为9个。所有患者中只有37%接受了充分的淋巴结评估。接受充分淋巴结评估的患者比例从1988年的32%增至2001年的44%(趋势P值<0.001, Cochr an - Armitage检验)。肿瘤晚期与充分的淋巴结评估在统计学上显著相关(接受充分淋巴结评估的比值比[OR]=2.27,95%置信区间[CI]=2.18至2.35)。老年患者(≥71岁,OR = 0.45,95% CI = 0.44至0.47)比年轻患者接受充分淋巴结评估的可能性小,左侧(OR = 0.45,95% CI = 0.44至0.47)或直肠(OR = 0.52,95% CI = 0.50至0.54)癌患者比右侧癌患者接受充分淋巴结评估的可能性小。在所有分析中,地理位置是充分淋巴结评估的重要预测因素,根据地理位置不同,该比例在33%至53%之间。

结论

2001年,大多数结直肠癌患者仍未接受充分的淋巴结评估。人口统计学变量,尤其是患者年龄和地理位置,与充分的淋巴结评估之间的关联表明,当地的手术和病理实践模式可能会影响淋巴结评估的充分性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验